Can Gio Pharmaceutical Joint Stock Company (OTC: CGP)
- Overview
- Trading
- Technical Analysis
- Financials
- Profile
- News & Events
- Industry Peers
- Documents
- Internal Trading
- Bonds
| 01/11/2022 | Audited FS 2019 |
| 07/02/2019 | 2019 Annual Shareholders’Meeting Documents |
| 07/02/2019 | Resolution of Annual Shareholders' Meeting 2019 |
| 05/03/2019 | Annual report 2018 |
| 04/17/2019 | Explanation for Audited Consolidated FS 2018 |
Name: Can Gio Pharmaceutical Joint Stock Company
Abbreviation:Cagipharm
Address: 43D/14 Hồ Văn Huê - P9 - Q.Phú Nhuận - Tp.HCM
Telephone: (84.28) 3979 8750 - 3979 8751 - 3979 8752
Fax: (08) 3979 8753
Email:Cagipharm@hcm.vnn.vn
Website:http://cagipharm.com.vn
Exchange: OTC
Sector: Manufacturing
Industry: Chemical - Pharmaceutical
Listing date: 10/26/2015
Chartered capital: 110,000,000,000
Listed shares: 10,735,708
Shares outstanding: 10,735,708
Status: Operating
Tax code: 0302664945
Establishment license:
Issued date: 07/31/2002
Business license: 4103001125
Issued date:
Main business scope:
- Sản xuất thuốc, sản xuất thiết bị y tế
- Thành lập các bệnh viện, trung tâm thử tương đương sinh học, các trung tâm chẩn đoán y khoa
- Xây dựng trung tâm phân phối thuốc đạt tiêu chuẩn GDP, hệ thống nhà thuốc đạt tiêu chuẩn GPP...
- 1982: The drugstore in Duyen Hai district under Pharmaceutical Company II was established as the precursor of Cagipharm;
- 2002: Can Gio Pharmaceutical Company, a State-owned enterprise, changed to a joint stock company, renamed as Can Gio Pharmaceutical JSC (Cagipharm). The initial charter capital of the company was VND5 bilion;
- 2008: Increased the charter capital to VND110 billion;
- 2015: Became a public company, traded on the Unlisted Public Company Market (UPCoM) (Ticker: CGP).
| Items | Unit |
|---|---|
| Price | VND |
| Volume | Shares |
| Foreigner's, Yield | % |
| Mkt Cap | bVND |
| Financial indicators | mVND |
| EPS, BVPS, Dividend | VND |
| P/E, F P/E, P/B | Times |
| ROS, ROA, ROE | % |
2. F PE is taken from the estimates of earnings announced by listed companies.
3. 3-month/6-month/12-month price charts are compiled from revised data.
